Regulatory Rapporteur May 2006

<< back to list of Issues

Front Cover
Volume 3 Issue 5

In This Issue

  • European risk management strategy
  • Incentives for SMEs
  • 10 years of EMEA CNS submissions - a rapidly acting sleep inducing agent
  • Consistency of Scientific Advice

Please login to view member only articles. Non-members may download the public articles.

TitleDownloadCategorySizeFile
Regulatory Rapporteur May 2006MembersFull Issue4MBPDF
A review of the European risk management strategy for medicinal products for human usePublic217KBPDF
10 years of EMEA CNS medicines – Part 5: Sonata/Zerene (Zaleplon) a rapidly acting sleep-inducing agentMembers182KBPDF
CRED Workshop: Life cycle management: Regulatory maintenance activitiesMembers163KBPDF
EMEA – Addressing the needs of small and medium-sized enterprises (SMEs)Members147KBPDF
EU Regulatory Intelligence: Updates March-April 2006Members126KBPDF
Focus on risk managementMembers90KBPDF
Ireland – Irish Medicines Board updateMembers270KBPDF
Italy: The Community Code becomes a realityMembers333KBPDF
Japan: National Health Insurance (NHI) price system and the major amendment points in April 2006Members291KBPDF
Scientific Advice through different European health authorities – and its outcome: a case studyMembers111KBPDF